POSTINOR

Medicinal product

(Invented) name

POSTINOR

Active substance (s)

Levonorgestrelis

Strength

1500 µg

Pharmaceutical form

burnoje disperguojama tabletė

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03AD01, Levonorgestrel

Marketing authorisation holder

Gedeon Richter Plc, Vengrija

Date of authorisation

2021-06-17

Date of renewal

Documents

4765 POSTINOR disperg tab PL 2025 02 07.docx

4765 Pakuotės lapelis 2025 02 07.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

CZ/H/0940/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Levonorgestrelis	1500 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106703	92805	1092805	lizdinė plokštelė	N1		Nereceptinis	LT/1/21/4765/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-06-17	Registruotas